[New quadruple combination intermittent therapy (cyclocytidine, adriamycin, 6MP and prednisolone: CyAMP) for adult acute leukemia (author's transl)].
D000208:Acute Disease; D000328:Adult; D000368:Aged; D003561:Cytarabine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004317:Doxorubicin / Q000008:administration & dosage* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage* / Q000627:therapeutic use; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage* / Q000627:therapeutic use
D003561:Cytarabine; D004317:Doxorubicin; D011239:Prednisolone; D015122:Mercaptopurine